Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
An immunotoxin and single-chain antibody technology, which is applied in the biological field to achieve obvious effects, simple and convenient preparation, and small toxic and side effects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] Example 1 Preparation of the fusion toxin of the present invention
[0024] The heavy and light chain variable regions of antibodies were amplified from known anti-EGFR hybridomas to construct anti-EGFR single-chain antibodies, which were specifically identified and affinity evolved using ribosome display technology. A fusion gene was constructed between Gelonin and the obtained single-chain antibody gene, and then expressed in E. coli.
[0025] Specifically: extract total RNA from anti-EGFR hybridoma cells (preserved in our laboratory), and then amplify the heavy and light chains (VH, VL) of Anti-EGFR by RT-PCR according to the designed library and specific primers Gene, select the band with good amplification effect for gel recovery, and insert into T vector. The ligation product was transformed into DH5a, a large number of single colonies were picked, the plasmid was extracted, and sent for sequencing. The sequencing results were analyzed by Jellyfish software, and...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
